News

An analysis from the Phase 3 CheckMate 77T trial confirms that perioperative nivolumab does not compromise health-related quality of life (HRQoL) in patients with resectable non-small cell lung cancer ...
A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...
A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who experienced non-central nervous system (CNS) progression on ...
A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated ...
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...
Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits the production of the hormone aldosterone, lowered systolic blood pressure by about 5% when added to ...
University of Leicester scientists have identified two extraordinary new fossils - tiny prehistoric flying reptiles, ...
Trial suggests using bedside scans instead of traditional stethoscopes shortens hospitalization and lowers costs.
The Europlanet Science Congress 2025 will be held jointly with the annual meeting of the American Astronomical Society’s Division of Planetary Science (EPSC-DPS2025) from 7–12 September 2025 at ...
A new study from the University of North Carolina at Chapel Hill shows that insect populations are rapidly declining even in relatively undisturbed landscapes, raising concerns about the health of ...
A long-term study spanning more than 50 years illustrates how the beavers that have returned to the Evo region in southern ...
The U.S. Air Force awarded startup SkyNano, led by Innovation Crossroads alumna Anna Douglas, a $1.25 million contract to ...